Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: Possible interactions with macrosomia

BMC Pregnancy and Childbirth

Volumn 10, Issue , 2010, Pages

  Grissa, Oussama ^a,b   Yessoufou, Akadiri ^a,c   Mrisak, Inès ^b   Hichami, Aziz ^a   Amoussou Guenou, Daniel ^c   Grissa, Abir ^b   Djrolo, François ^c   Moutairou, Kabir ^c   Miled, Abdelhedi ^b   Khairi, Hédi ^b   Zaouali, Monia ^b   Bougmiza, Iheb ^b   Zbidi, Aabdelkarim ^b   Tabka, Zouheir ^b   Khan, Naim A ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLUCOSE; GROWTH FACTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; TRIACYLGLYCEROL; URIC ACID; SIGNAL PEPTIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETOPLACENTAL UNIT; HUMAN; HYPERGLYCEMIA; MACROSOMIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PLACENTA CIRCULATION; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UPREGULATION; BLOOD; CASE CONTROL STUDY; CHEMISTRY; GENETICS; METABOLISM; PHYSIOLOGY; PLACENTA; TUNISIA;

ADULT; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; EPIDERMAL GROWTH FACTOR; FEMALE; FETAL MACROSOMIA; FIBROBLAST GROWTH FACTOR 2; GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PLACENTA; PREGNANCY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER; TUNISIA; UP-REGULATION;

EID: 77649140329     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-10-7     Document Type: Article

References (48)

1. Shen SJ, Wang CY, Nelson KK, jansent M, Ilan J. Expression of insulin-like growth factor II in human placentas from normal and diabetic pregnancies. Proc Nati Acad Sci USA 1986, 83:9179-9182.
2. Silverman BL, Landsberg L, Metzger BE. Foetal hyperinsulinism offspring of diabetic mothers: association with the subsequent development of childhood obesity. Ann N Y Acad Sci 1993, 699:36-45. 10.1111/j.1749-6632.1993.tb18835.x, 8267335.
3. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, Yudkin JS, Wilkinson AR, Dunger DB. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998, 83:3550-3557. 10.1210/jc.83.10.3550, 9768663.
4. Khan NA. Role of lipids and fatty acids in macrosomic offspring of diabetic pregnancy. Cell Biochem Biophys 2007, 48:79-88. 10.1007/s12013-007-0019-4, 17709877.
5. Merzouk H, Khan NA. Implication of lipids in macrosomia of diabetic pregnancy: can n-3 polyunsaturated fatty acids exert beneficial effects?. Clin Sci 2003, 105:519-529. 10.1042/CS20030143, 12904180.
6. Yessoufou A, Soulaimann N, Merzouk SA, Moutairou K, Ahissou H, Prost J, Simonin AM, Merzouk H, Hichami A, Khan NA. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int J Obes 2006, 30:739-750.
7. Grissa O, Atègbo JM, Yessoufou A, Tabka Z, Miled A, Jerbi M, Dramane KL, Moutairou K, Prost J, Hichami A, Khan NA. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl Res 2007, 150:164-171. 10.1016/j.trsl.2007.03.007, 17761369.
8. Khan NA, Yessoufou A, Kim M, Hichami A. N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia. J Autoimmun 2006, 26:268-277. 10.1016/j.jaut.2006.03.003, 16713180.
9. Khan NA. Role of T-cells in diabetic pregnancy and macrosomia. Ind J Biochem Biophys 2007, 44:344-409.
10. Atègbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006, 91:4137-4143. 10.1210/jc.2006-0980, 16849405.
11. Fowden AL. The role of insulin in prenatal growth. J Dev Physiol 1989, 12:173-182.
12. Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LF, Breier BH, Johnstone FD. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol (Oxf) 2007, 66(3):322-328. 10.1111/j.1365-2265.2006.02719.x, 17302863.
13. Roth S, Abernathv MP, Lee WH, Pratt L, Denne S, Golichowski A, Pescovitz OH. Insulin-like growth factor I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies. J Soc Gynecol Invest 1996, 3:78-84.
14. Lauszus FF. The clinical significance of IGF-I in maternal serum during pregnancy in type 1 diabetes. Curr Diabetes Rev 2007, 3:194-197. 10.2174/157339907781368922, 18220671.
15. Karabulut AK, Layfield R, Pratten MK. Growth promoting effects of human placental lactogen during early organogenesis: a link to insulin-like growth factors. J Anat 2001, 198:651-662. 10.1046/j.1469-7580.2001.19860651.x, 1468255, 11465858.
16. Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human foetal growth and development. J Pediatr Endocrinol Metab 2000, 13:343-356.
17. Westgate JA, Lindsay RS, Beattie J, Pattison NS, Gamble G, Mildenhall LF, Breier BH, Johnstone FD. Hyperinsulinemia in cord blood in mothers with type 2 diabetes and gestational diabetes mellitus in New Zealand. Diadetes Care 2006, 29(6):1345-1350.
18. Fee BA, Weil WB. Body composition of infants of diabetic mothers by direct analysis. Ann N Y Acad Sci 1963, 110:869-897. 10.1111/j.1749-6632.1963.tb15808.x, 14061691.
19. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003, 133:1674-1683.
20. Zollers WG, Babishkin JS, Pepe GJ, Albrecht ED. Developmental regulation of placental insulin-like growth factor (IGF)-II and IGF-binding protein-I and -2 messenger RNA expression during primate pregnancy. Biol Reprod 2001, 4:1208-1214.
21. Roth S, Abernathv MP, Lee WH, Pratt L, Denne S, Golichowski A, Pescovitz OH. Insulin-like growth factor I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies. J Soc Gynecol Invest 1996, 3:78-84.
22. Lauszus FF, Klebe JG, Flyvbjerg A. Macrosomia associated with maternal serum insulin-like growth factor -I and II in diabetic pregnancy. Obstet Gyneco 2001, 197:734-741.
23. Hill WC, Pelle-Day G, Kitzmiller JL, Spencer EM. Insulin-like growth factors in fetal macrosomia with and without maternal diabetes. Horm Res Pediatr 1989, 32:178-182.
24. Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D'Ercole AJ, Underwood LE. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 1990, 127:1278-1286. 10.1210/endo-127-3-1278, 1696882.
25. Ashton IK, Spencer EM. Effect of partially purified human somatomedin on human foetal and postnatal cartilage in vitro. Early Hum Dev 1983, 8:135-140. 10.1016/0378-3782(83)90069-5, 6884255.
26. Kniss DA, Shubert PJ, Zimmerman PD, Landon MB, Gabbe SG. Insulin like growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first trimester chorionic villi. J Reprod Med 1994, 39:249-256.
27. Bhaumick B, Danilkewich AD, Bala RM. Altered placental insulin and insulin-like growth factor-I receptors in diabetes. Life Sci 1988, 42:1603-1614. 10.1016/0024-3205(88)90439-0, 2966883.
28. Lee PD, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp 1993, 204:4-29.
29. Yan-Jun L, Tsushima T, Minei S, Sanaka M, Nagashima T, Yanagisawa K, Omori Y. Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia. Endocr J 1996, 43:221-231. 10.1507/endocrj.43.Suppl_S89, 9026269.
30. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. Insulin- like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995, 80:2282-2288. 10.1210/jc.80.8.2282, 7543110.
31. Kalme T, Loukovaara M, Koistinen H, Koistinen R, Seppälä M, Leinonen P. Factors regulating insulin-like growth factor binding protein-3 secretion from human hepatoma (HepG2) cells. J Steroid Biochem Mol Biol 2001, 78:131-135. 10.1016/S0960-0760(01)00089-9, 11566437.
32. Mirlesse V, Frankenne F, Alsat E, Poncelet M, Hennen G, Evain-Brion D. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res 1993, 34:439-442. 10.1203/00006450-199310000-00011, 8255674.
33. Lee ZS, Chan JC, Yeung VT, Chow CC, Lau MS, Ko GT, Li JK, Cockram CS, Critchley JA. Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care 1999, 22:1450-1457. 10.2337/diacare.22.9.1450, 10480508.
34. Lacroix MC, Devinoy E, Cassy S, Servely JL, Vidaud M, Kann G. Expression of growth hormone and its receptor in the placental and foeto-maternal environment during early pregnancy in sheep. Endocrinology 1999, 140:5587-5597. 10.1210/en.140.12.5587, 10579322.
35. Misra M, Bredella MA, Tsai P, Mendes N, Miller KK, Klibanski A. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab 2008, 295:385-392.
36. Gogg S, Smith U. Epidermal growth factor and transforming growth factor mimic the effects of insulin in human fat cells and augment downstream signaling in insulin resistance. J Biol Chem 2002, 277:36045-36051. 10.1074/jbc.M200575200, 12138086.
37. Loukovaara M, Leinonen P, Teramo K, Andersson S, Alfthan H, Stenman UH. Diabetic Pregnancy Associated With Increased Epidermal Growth Factor in Cord Serum at Term. Obstet Gynecol 2004, 240:243-103.
38. Masuyama H, Hiramatsu Y, Kudo T. Effect of epidermal growth factor on placental amino acid transport and regulation of epidermal growth factor receptor expression of hepatocyte in rat. J Perinat Med 1996, 24:213-220. 10.1515/jpme.1996.24.3.213, 8827569.
39. Hofmann GE, Abramowicz JS. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet Gynecol Scand 1990, 69:217-221. 10.3109/00016349009028683, 2220342.
40. Hill DJ, Tevaarwerk GJ, Caddell C, Arany E, Kilkenny D, Gregory M. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to foetal and placental size. J Clin Endocrinol Metab 1995, 80:2626-2632. 10.1210/jc.80.9.2626, 7673405.
41. Amaya E, Musci TJ, Kirschner MW. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in ken opus embryos. Cell 1991, 66:257-270. 10.1016/0092-8674(91)90616-7, 1649700.
42. Hill DJ, Milner RDG. Insulin as a growth factor. Pediatr Res 1985, 19:879-886. 10.1203/00006450-198509000-00001, 2413420.
43. Hoch RV, Soriano P. Roles of PDGF in animal development. Development 2003, 130:4769-4784. 10.1242/dev.00721, 12952899.
44. Nyström HC, Lindblom P, Wickman A, Andersson I, Norlin J, Fäldt J, Lindahl P, Skøtt O, Bjarnegård M, Fitzgerald SM, Caidahl K, Gan LM, Betsholtz C, Bergström G. Platelet-derived growth factor B retention is essential for development of normal structure and function of conduit vessels and capillaries. Cardiovasc Res 2006, 71:557-565. 10.1016/j.cardiores.2006.05.019, 16831408.
45. Heinig J, Wilhelm S, Müller H, Briese V, Bittorf T, Brock J. Determination of cytokine mRNA-expression in term human placenta of patients with gestational hypertension, intrauterine growth retardation and gestational diabetes mellitus using polymerase chain reaction. Zentralbl Gynakol 2000, 122:413-418. 10.1055/s-2000-10606, 11005132.
46. Dixit M, Zhuang D, Ceacareanu B, Hassid A. Treatment with insulin uncovers the motogenic capacity of nitric oxide in aortic smooth muscle cells: dependence on Gab1 and Gab1-SHP2 association. Circ Res 2003, 93:113-123.
47. Zhuang D, Pu Q, Ceacareanu B, Chang Y, Dixit M, Hassid A. Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B. Am J Physiol Heart Circ Physiol 2008, 295:163-173.
48. Holmgren L, Glaser A, Pfeifer-Ohlsson S, Ohlsson R. Angiogenesis during human extra embryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 1991, 113:749-754.